The United States is developing a COVID-19 vaccine
A major US pharmaceutical company announced that it is researching two potential COVID-19 vaccines and an experimental drug against COVID-19. As part of its acquisition of an Austrian manufacturer, the company also acquired an experimental vaccine and collaborated on the development of a second Candidate vaccines and potential drugs. In addition, it also pointed out that the candidate vaccine will use the technology based on its Ebola Zaire virus vaccine and is the first rVSV vaccine approved for use in humans. There are currently more than 100 new crown vaccine R & D programs in the world, increasing market expectations for the vaccine to be available within the year and boosting market sentiment.
U.S. Republican congressional Senate leader may launch new anti-epidemic relief bill
McConnell, the leader of the Senate of the Republican Congress of the United States, said that the performance of several US states after the restart of the economy will help Congress assess whether it is necessary to introduce a new anti-epidemic bill. It also stated that if necessary, it will continue to provide unemployment benefits to those in need. Remarks have increased market expectations for the US government to introduce more economic stimulus packages in the future.
Z. com Bullion is an affiliate of GMO Financial Holdings, Inc., a Japanese listed group. The risk of loss in leveraged foreign exchange trading & margin trading can be substantial. Visit the company website to read full risk warning. https://bullion.z.com/en/about/legal/risk/